
In Stock
10mg
Dual Incretin Receptor Engagement
Tirzepatide is a focus for researchers studying incretin biology. As a dual agonist, it engages both the GIP and GLP-1 receptors, providing a model for examining how combined incretin signaling differs from selective GLP-1 activation. Studies use Tirzepatide to investigate receptor-binding dynamics and the synergistic effects of dual engagement on pancreatic and metabolic signaling in cellular models.
Glucose Homeostasis & Insulin Response
In metabolic research, Tirzepatide is investigated for its influence on glucose-dependent insulin secretion. Researchers study how dual incretin signaling modulates the insulinotropic response in pancreatic beta-cell models, examining the interplay between the two receptor pathways in regulating glucose handling.
Adipose Metabolism & Energy Partitioning
Recent studies have utilized Tirzepatide to investigate effects on lipid metabolism. By examining how combined GIP and GLP-1 engagement influences adipose signaling and substrate partitioning, researchers explore the peptide's role in energy-balance and body-composition research within preclinical models.
For research use only.
testimonials
peptides
Our most popular peptides, in high-demand this year

verified coa's
The most powerful weight loss peptide studied, with clinical trials showing up to 24% body weight reduction in 48 weeks.
Trusted by 150+ Customers
